Sang Hyuk Park Hyun-Sook Chi Young-Uk Cho Seongsoo Jang Chan-Jeoung Park Ho-Joon Im
10.3343/alm.2013.33.1.80
Ann Lab Med
2013 Jan;33(1):80-3.
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/23301228/
Fusion Proteins, bcr-abl / metabolism Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
Fusion Proteins, bcr-abl / metabolism Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis Case Reports Letter Adolescent Antineoplastic Agents / therapeutic use Benzamides / therapeutic use Chromosome Deletion Chromosomes, Human, Pair 7 Drug Resistance, Neoplasm Fusion Proteins, bcr-abl / genetics Humans Imatinib Mesylate Immunophenotyping Karyotyping Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism Male Piperazines / therapeutic use Pyrimidines / therapeutic use Real-Time Polymerase Chain Reaction Antineoplastic Agents Benzamides Piperazines Pyrimidines Imatinib Mesylate Fusion Proteins, bcr-abl Chromosome 7, monosomy
PMC3535203
23301228
A case with coexistence of major and minor BCR/ABL fusion transcript at lymphoblastic crisis of chronic myelogenous leukemia in patients with major BCR/ABL positivity during chronic phase
2013